 |
| Research article summary (published 29 Nov 2009): |
Dasatinib after allogeneic stem cell transplantation in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
Full Abstract
No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Author information
Author/s: de Castro, Cláudio Galvão (CG); Gregianin, Lauro José (LJ); Meneses, Clarice Franco (CF); Brunetto, Algemir Lunardi (AL);
Journal and publication information
Publication Type: Case Reports; Comment; Letter
Journal: Pediatric blood & cancer (Pediatr Blood Cancer), published in United States. (Language: eng)
Reference: 2009-Dec; vol 53 (issue 6) : pp 1161
Dates: Created 2009/09/16; Completed 2009/10/13;
PMID: 19621456, status: MEDLINE (last retrieval date: 10/13/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentOn: Pediatr Blood Cancer. 2009 Jul;52(7):891-2. (PMID: 19202569)
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Joseph Brandwein.
30 Dec 2006 - Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia. 30 Oct 2005
- Clonal evolution with +11q 13, t(1;7) and t(1;4) at relapse in a patient with Ph positive acute lymphocytic leukemia (ALL) treated with single agent front line imatinib followed by dasatinib.
29 Nov 2007 - Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.
13 Jan 2008 - Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure. 30 May 2008
- The FDA approves new leukemia drug; expands use of current drug. 30 Oct 2006
- Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. 31 May 2008
- Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study. 9 May 2007
- Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practice. 30 Aug 2006
- Isothiazolopyrimidines--new group of anticancer agents. I. 30 Dec 1986
Related Article Map
10/30/1972
5/31/2008
Higher Relevance Score (100)
Lower Relevance Score (75)
Legend: - FREE Full text Article. - Abstract only. - Title only. More help.
See a large map of 100+ related articles.